ClinicalTrials.Veeva

Menu

Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure

K

Karolinska University Hospital

Status

Completed

Conditions

Long Term Outcome

Treatments

Radiation: CT scan
Radiation: MRI
Behavioral: Cognitive function

Study type

Observational

Funder types

Other

Identifiers

NCT01763060
Dnr 2012/986-31/3
Long term outcome (Other Identifier)

Details and patient eligibility

About

Patients treated with Extracorporeal Membrane Oxygenation (ecmo) for severe respiratory or circulatory failure show severe long term disability due to impaired lung -, cerebral-, cognitive function and impaired quality of life. This study investigates the long term outcome of all patients who are still alive three years after ECMO treatment for severe respiratory failure during the H1N1 2009 pandemic at the Karolinska University Hospital.

Enrollment

7 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Survivors of ECMO treatment for influenza a/h1n1 pneumonia during 2009/2010 pandemics at the ECMO Center Karolinska

Exclusion criteria

  • None

Trial design

7 participants in 1 patient group

ECMO survivors
Description:
CT scan of the chest of all ECMO survivors after 2009/2010 pandemics Tests for cognitive function MRI of the brain Lung function
Treatment:
Radiation: CT scan
Radiation: MRI
Behavioral: Cognitive function

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems